The US FDA has granted Fast Track Designation to SOTIO [...]
Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]
The US FDA has granted Fast Track Designation to SOTIO [...]
Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]